本文来源:时代财经 作者:张羽岐GLP-1赛道正成为医药零售市场的新标的。当下,中国医药零售市场正经历深刻变革,一方面,政策推动“互联网+医疗健康”快速发展,线上医药零售占比持续提升;另一方面,消费者健康需求日益多元化,从传统药品向大健康、慢病管理及创新疗法延伸。尤其是在减肥与代谢领域,GLP-1受体激动剂,如司美格鲁肽、替尔泊肽等的爆火,不仅重塑了市场格局,也催生了新的消费场景,医药零售端从单纯...
Source Link本文来源:时代财经 作者:张羽岐GLP-1赛道正成为医药零售市场的新标的。当下,中国医药零售市场正经历深刻变革,一方面,政策推动“互联网+医疗健康”快速发展,线上医药零售占比持续提升;另一方面,消费者健康需求日益多元化,从传统药品向大健康、慢病管理及创新疗法延伸。尤其是在减肥与代谢领域,GLP-1受体激动剂,如司美格鲁肽、替尔泊肽等的爆火,不仅重塑了市场格局,也催生了新的消费场景,医药零售端从单纯...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.